Literature DB >> 14189696

EVALUATION OF SERUM TRYPSIN INHIBITOR ACTIVITY IN THE DETECTION OF MALIGNANT DISEASE.

J H KEMP, J M JOHNSTONE.   

Abstract

Entities:  

Keywords:  BLOOD; CLINICAL RESEARCH; MASS SCREENING; NEOPLASM DIAGNOSIS; SPECTROPHOTOMETRY; TRYPSIN INHIBITORS

Mesh：

Substances：

Year:  1964        PMID： 14189696      PMCID： PMC2071315          DOI： 10.1038/bjc.1964.45

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  3 in total

1.  A SPECTROPHOTOMETRIC METHOD FOR MEASURING SERUM TRYPSIN INHIBITOR CAPACITY.

Authors:  G M HOMER; B J KATCHMAN; R E ZIPF
Journal:  Clin Chem       Date:  1963-08       Impact factor: 8.327

2.  Fibrinolysis in the organism.

Authors:  T ASTRUP
Journal:  Blood       Date:  1956-09       Impact factor: 22.113

3.  Studies of various tests for malignant neoplastic diseases. VII. Serum inhibitors of chymotrypsin and trypsin.

Authors:  A C PEACOCK; J J SHEEHY
Journal:  J Natl Cancer Inst       Date:  1952-02       Impact factor: 13.506
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.